Jasper Therapeutics, Inc. (NASDAQ:JSPR) Financings

Jasper Therapeutics, Inc.

Financings

RaiseDate
Private placement of non-voting convertible preferred stock
Closed: US$132M raised · Piper Sandler & Co. +1
Dealers: Piper Sandler & Co. (lead), LifeSci Capital LLC (co-lead)
Buyers: Affinity Asset Advisors, LLC (co-led the private placement); Ikarian Capital LLC (co-led the private placement); Columbia Threadneedle Investments; Sirenia Capital Management LP; Brahma Capital; Balyasny Asset Management; SilverArc Capital; Squadron Capital Management; Nazare Partners LP; Mirador Therapeutics
Use of proceeds: Fund development of the combined company's pipeline through the second half of 2028
Aug 17, 2026
Public offering of common stock and warrants
Closed: US$30M raised · US$2.43 a share · Warrants at US$2.92 for 48 months · TD Cowen
Dealers: TD Cowen (lead)
Use of proceeds: Extends cash runway through the first half of 2026
Nov 10, 2025

Read by 6ix AI from the company's releases